Nyxoah Posts Strong Q3 Results, Gears Up for Genio’s Anticipated US Launch
Summary: Nyxoah reported third-quarter financial results, showcasing a 30% increase in sales and raising €24.6 million to bolster its anticipated US commercialization of the Genio neurostimulation system for obstructive sleep apnea. The company also highlighted progress in its US operations, including the presentation of promising DREAM study data and key leadership hires to drive the…